Sign in
4

Changes in Ownership

Opus Genetics, Inc. Filed Acc 0001140361-26-035912

Chief Financial Officer sold 28,000 shares at $4.54 ($127,212)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gagnon Robert E. Chief Financial Officer 2026-09-03 Sale −28,000 $4.54 $127,212 556,375 D: show line 1 in the form
Open-market sales · 28,000 sh · avg $4.54 · $127,212
Loading xslF345X06/form4.xml…